Chapter 5: Viral and Host Factors in Human Papillomavirus Persistence and Progression
Open Access
- 1 June 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI Monographs
- Vol. 2003 (31) , 35-40
- https://doi.org/10.1093/oxfordjournals.jncimonographs.a003480
Abstract
Understanding the interdependent roles that host and viral factors play in cervical cancer pathogenesis is important for distinguishing women at the highest risk of human papillomavirus (HPV) persistence and progression to cervical cancer. Ongoing research on viral factors such as viral variants is providing important clues regarding HPV oncogenesis; the comprehensive characterization of the HPV genome and the function of viral genes by HPV type and variant will further this understanding. Although the biologic importance of viral integration and viral load measurements in cervical neoplasia is still being debated, available data are difficult to interpret because of methodologic limitations; to sufficiently address the importance of these events will require further methods validation and subsequent application in epidemiologic studies. Continued and expanded investigation of host immune responses—humoral, cellular, and innate immunity—should specifically address the outcomes of HPV persistence and progression to cervical cancer. Molecularly based assays paired with functional assays will be integral toward the identification and validation of key immune pathways and genes specifically relevant to cervical cancer pathogenesis. Novel technologies such as gene expression microarrays will further allow comprehensive identification of relevant genes that are important at various stages of cervical pathogenesis. The study of viral and host factors will undoubtedly lead to markers that may hold diagnostic and/or prognostic value; the clinical validity and utility of these molecular events will, therefore, need to be carefully assessed before implementation in a population setting.Keywords
This publication has 29 references indexed in Scilit:
- Host and viral genetics and risk of cervical cancer: a reviewVirus Research, 2002
- Association of Human Papillomavirus Type 58 Variant With the Risk of Cervical CancerJNCI Journal of the National Cancer Institute, 2002
- Viral load of human papillomavirus and risk of CIN3 or cervical cancerThe Lancet, 2002
- Effects of Age and Human Papilloma Viral Load on Colposcopy Triage: Data From the Randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)JNCI Journal of the National Cancer Institute, 2002
- Oncogenic Human Papillomavirus Infection and Cervical Lesions in Aboriginal Women of Nunavut, CanadaSexually Transmitted Diseases, 2001
- Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasiaJournal of General Virology, 2000
- Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control studyThe Lancet, 2000
- HPV DNA Testing in Cervical Cancer ScreeningJAMA, 2000
- Association Between Human Papillomavirus Type 18 Variants and Histopathology of Cervical CancerJNCI Journal of the National Cancer Institute, 1997
- Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potentialInternational Journal of Cancer, 1995